Market Tracker

07/28 4:16pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

134.89
Delayed Data
As of 4:00pm ET
 -1.18 / -0.87%
Today’s Change
71.63
Today|||52-Week Range
138.94
+24.41%
Year-to-Date
Trade-Ideas: Ligand Pharmaceuticals (LGND) Is Today's "Perilous Reversal" Stock
Jul 21 / TheStreet.com - Paid Partner Content
3 Biotech Stocks for Conservative Investors
Jul 17 / MotleyFool.com - Paid Partner Content
Ligand Pharmaceuticals (LGND) Jumps: Stock Rises 5.5%
Jul 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close136.07
Today’s open136.50
Day’s range134.71 - 138.64
Volume339,315
Average volume (3 months)386,024
Market cap$2.8B
Dividend yield--
Data as of 4:00pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)+2,064.46%
Earnings growth (this year)+1.78%
Earnings growth (next 5 years)+53.87%
Revenue growth (last year)+11.43%
P/E ratio10.9
Price/Sales32.00
Price/Book8.92

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC-0.23-1.16%
MDCOMedicines Co+0.93+2.45%
CBPOChina Biologic Produ...+3.90+3.31%
IPXLImpax Laboratories I...+0.03+0.10%
Data as of 4:00pm ET, 07/28/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)$0.40
Annual revenue (last year)$71.9M
Annual profit (last year)$257.3M
Net profit margin357.80%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts